RxDoctor Payments Data

Aarathi Cholkeri

Gynecology · El Segundo, CANPI 1205857281

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $117,995 and has fallen 100.0% since, to $56 in 2025. Among gynecology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$127,853in general payments, 2019–2025

Across 202 payments — averaging $632.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$81K
  • Covidien LP$16K
  • Daiichi Sankyo Inc.$11K
  • American Regent$7K
  • Boston Scientific$6K
  • KARL Storz Endoscopy-america$3K
  • plus $4K from 14 others

What the payments were for

  • Consulting fees$40,19231%
  • Speaking & faculty fees$68,19053%
  • Travel & lodging$13,34010%
  • Food & beverage$6,1135%
  • Gifts$180%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$127,853 in reported general payments places this provider in the 95th percentile of 247 gynecology providers in California.

See all gynecology providers in California

Other gynecology in El Segundo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →